Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001387131-20-007841
Filing Date
2020-08-25
Accepted
2020-08-25 09:02:38
Documents
1
Group Members
AIGH CAPITAL MANAGEMENT, LLCAIGH INVESTMENT PARTNERS, L.L.C.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP sls-sc13g_080320.htm SC 13G 71189
  Complete submission text file 0001387131-20-007841.txt   72818
Mailing Address 101 EAST 52ND ST NEW YORK NY 10022
Business Address
HIRSCHMAN ORIN (Filed by) CIK: 0001131362 (see all company filings)

Type: SC 13G

Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Subject) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-84090 | Film No.: 201129659
SIC: 2834 Pharmaceutical Preparations